Skip to main content
. 2023 Feb 28;14:1096401. doi: 10.3389/fneur.2023.1096401

Table 1.

Participant demographic information for non-faller and faller groups.

Non-fallers (N = 17) Fallers (N = 17) p
Age (yrs) 66.82 (6.61) 68.69 (11.10) 0.29
Disease Duration (yrs) 7.29 (5.6) 9.24 (4.58) 0.14
H and Y ON (#) 2 (0) 2.18 (0.53) 0.164
H and Y OFF (#) 2.06 (0.24) 2.29 (0.59) 0.153
MDS-UPDRS Part III total score ON (#) 29.47 (8.49) 32.65 (9.92) 0.36
MDS-UPDRS Part III total score OFF (#) 43.88 (11.3) 46.18 (10.02) 0.39
MDS-UPDRS Part III PIGD score ON (#) 2.59 (1.42) 3.53 (2.62) 0.34
MDS-UPDRS Part III PIGD score OFF (#) 3.53 (1.66) 5.35 (3.28) 0.09
MoCA total score (#) 26.94 (2.38) 26.88 (2.93) 0.81
LEDD total score (mg/day) 1,541.94 (2,342.53) 1,128.1 (533.18) 0.36
PDQ39 total score (%) 13.91 (7.3) 23.3 (14.82) 0.13
PDQ39 Mobility score (%) 11.91 (12.14) 21.76 (18.68) 0.11
MDS-UPDRS Dyskinesia ON (#) 0.35 (0.49) 0.53 (0.51) 0.31
NFOGQ past month (#) 0.47 (0.51) 0.76 (0.44) 0.08
Activity measures from daily life
Number of days 6.76 (0.56) 6.41 (1.28) 0.31
Total hours of recording 64.57 (8.64) 62.07 (16.02) 0.58
Bouts/hours (#) 7.82 (3.05) 7.65 (4.16) 0.70
Strides/hours (#) 149.87 (60.95) 161.07 (94.82) 0.85
Turns/hours (#) 20.19 (9.33) 21.34 (15.71) 0.97

H and Y, Hoehn and Yahr scale; MDS-UPDRS Part III, Movement Disorders Society-Unified Parkinson's Disease Rating Scale, motor sub-score; MoCA, Montreal Cognitive Assessment; LEDD, levodopa equivalent daily dose; PDQ39, Parkinson's Disease Questionnaire-39; NFOGQ Past Month, First question of NFOGQ for freezing in last month.